Altered platelet monoamine oxidase activity in affective disorders

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Platelet monoamine oxidase (MAO) activity has been implicated in affective disorders.
• Previous research suggests a link between MAO activity and depression severity.

Purpose of the Study:

• To investigate platelet MAO activity in patients with primary depressive illness.
• To differentiate MAO activity patterns between subgroups of depression (reactive, endogenous unipolar, endogenous bipolar).
• To examine the influence of illness state and lithium treatment on these MAO activity differences.

Main Methods:

• Assessing platelet MAO activity in patients with primary depressive illness and control groups.
• Subgrouping patients based on depression type (reactive, endogenous unipolar, endogenous bipolar).
• Analyzing MAO activity using specific substrates (tyramine, benzylamine) and evaluating effects of lithium carbonate therapy.

Main Results:

• Platelet MAO activity was elevated in primary depressive illness and positively correlated with severity.
• Reactive depression subgroup showed no significant difference in MAO activity compared to controls.
• Endogenous unipolar depression exhibited high platelet MAO activity, while endogenous bipolar depression showed low activity.
• These MAO activity differences between unipolar and bipolar patients persisted in the well state but were normalized after lithium therapy.
• Differences were observed with tyramine but not benzylamine as a substrate.

Conclusions:

• Altered platelet MAO activity is a feature of primary depressive illness, with distinct patterns in endogenous unipolar and bipolar subtypes.
• These MAO activity variations may be genetically determined and are differentially affected by lithium treatment.
• The substrate specificity (tyramine vs. benzylamine) suggests specific MAO isoenzyme involvement in affective disorders.